Veeva announces new product integration with Salesforce
Veeva Systems has announced new integration between Salesforce Marketing Cloud and Veeva CRM for increased visibility.
Archives for March 15, 2017
DSM Sinochem licenses enzymatic antibiotic production tech to Sandoz; sues Weiqida
DSM Sinochem Pharmaceuticals has licensed enzyme-based antibiotic production IP to Sandoz and accused Sinopharm Weiqida Pharmaceutical of patent infringement.
Misbranded epilepsy drug API lands FDA warning for Chinese ingredient maker
The US FDA has slammed China’s Lumis Global Pharmaceuticals for problems documenting and labelling active pharmaceutical ingredients.
Heptares, Daiichi Sankyo to develop small molecules for pain treatment
Heptares Therapeutics has entered into a drug discovery and licensing agreement with Daiichi Sankyo – providing further validation of the company’s structure-based drug design approach, says CEO.
Reader's poll
American-made biosimilars a differentiator in US market, Coherus
US patients and physicians favour domestically-made biosimilars according to Coherus Biosciences. But if quality is assured should the manufacturing location matter?
Celerion adds biometric fingerprint tech across units
Celerion has implemented Verified Clinical Trials’ (VCT) biometric fingerprint technology to address “significant amount” of participants dual enrolling at Ph I units.
Ideal Cures 'building business' with PE investment
Idea Cures has announced an investment from the global private equity firm, TA Associates, as it aims to grow its manufacturing business.